申请人:Lu Tianbao
公开号:US20090098181A1
公开(公告)日:2009-04-16
The invention is directed to triazolopyridazine compounds of Formula I:
where R
1
, R
5
, R
6
, R
7
, R
8
, and A are as defined herein, the use of such compounds as protein tyrosine kinase modulators, particularly inhibitors of c-Met, and the use of such compounds to reduce or inhibit kinase activity of c-Met in a cell or a subject, and modulate c-Met expression in a cell or subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to c-Met. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as cancers and other cell proliferative disorders.
本发明涉及式I的三唑并吡嗪化合物:其中R1、R5、R6、R7、R8和A如本文所定义,使用这种化合物作为蛋白酪氨酸激酶调节剂,特别是c-Met的抑制剂,并使用这种化合物来减少或抑制细胞或受体中c-Met的激酶活性,调节细胞或受体中c-Met的表达,并使用这种化合物预防或治疗细胞增殖性疾病和/或与c-Met相关的疾病。本发明还涉及包含本发明化合物的制药组合物以及治疗癌症和其他细胞增殖性疾病的方法。